Evaluation of combined bevacizumab plus irinotecan therapy in brain tumors using magnetic resonance imaging measures of relative cerebral blood volume-Reference-Cited by-同舟云学术

Evaluation of combined bevacizumab plus irinotecan therapy in brain tumors using magnetic resonance imaging measures of relative cerebral blood volume

Published:2011-12-28 Issue:4 Volume:68 Page:1266-1272
ISSN:0740-3194
Container-title:Magnetic Resonance in Medicine
language:en
Short-container-title:Magnetic Resonance Medicine

Author:

Pechman Kimberly R.,Donohoe Deborah L.,Bedekar Devyani P.,Kurpad Shekar N.,Schmainda Kathleen M.

Funder

National Cancer Institute at the National Institutes of Health

MCW Advancing Healthier Wisconsin/Translational Brain Tumor Research Program

Publisher

Wiley

Subject

Radiology Nuclear Medicine and imaging

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mrm.23315/fullpdf

Reference35 articles.

1. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med,2005

2. Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma;Stupp;J Clin Oncol,2010

3. Trimodal cancer treatment: beneficial effects of combined antiangiogenesis, radiation, and chemotherapy;Huber;Cancer Res,2005

4. Radiotherapy and temozolomide for newly diagnosed glioblastoma: Recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial;Mirimanoff;J Clin Oncol,2006

5. Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan;Zuniga;J Neurooncol,2009

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potent in vivo efficacy of oral gallium maltolate in treatment-resistant glioblastoma;Frontiers in Oncology;2024-01-15

2. Correlation of radiological and immunochemical parameters with clinical outcome in patients with recurrent glioblastoma treated with Bevacizumab;Clinical and Translational Oncology;2019-03-15

3. Gallium Maltolate Disrupts Tumor Iron Metabolism and Retards the Growth of Glioblastoma by Inhibiting Mitochondrial Function and Ribonucleotide Reductase;Molecular Cancer Therapeutics;2018-03-28

4. RNA Sequencing of Tumor-Associated Microglia Reveals Ccl5 as a Stromal Chemokine Critical for Neurofibromatosis-1 Glioma Growth;Neoplasia;2015-10

5. Brain perfusion and permeability in patients with advanced, refractory glioblastoma treated with lomustine and the transforming growth factor-β receptor I kinase inhibitor LY2157299 monohydrate;Oncology Letters;2015-04-08